newsfilter
← Latest News
PR Newswire·

Mallinckrodt's Hobart, N.Y. Site Recognized With Two Manufacturing Leadership Awards

Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, today announced that its Specialty Generics business has been...